相关实验视频

Updated: Jun 21, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

纳米-巴西勒斯卡尔梅特-盖林免疫疗法用于改善膀癌治疗

Sheng Zeng¹, Shaoqiang Xing², Yifei Zhang²

¹Department of Urology, Tianjin First Central Hospital, Tianjin 300192, China.

Journal of Zhejiang University. Science. B

|July 16, 2024

概括

纳米BCG和基因工程BCG通过增强免疫反应和克服分娩挑战,为膀癌免疫疗法显示出希望. 这些先进的Bacillus Calmette-Guérin (BCG) 配方旨在提高治疗效率并降低毒性.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

癌症免疫疗法是关键的治疗方式,但在输送和毒性方面面临局限性.
结核疫苗Bacillus Calmette-Guérin (BCG) 具有抗瘤特性,用于治疗膀癌.
纳米材料和基因工程为提高免疫疗法的有效性提供了潜在的解决方案.

研究的目的:

审查纳米BCG和基因工程BCG用于膀癌免疫治疗的发展.
讨论这些先进的BCG配方的潜在好处和挑战.
突出突出克服免疫治疗局限性的进展.

主要方法:

对BCG疗法,纳米BCG和基因工程BCG的现有文献的审查.
分析纳米材料和基因工程改善免疫反应的机制.
评估膀癌治疗中的临床应用和挑战.

主要成果:

纳米BCG和基因工程BCG可以增强免疫激活,调节瘤微环境.
这些新的BCG配方旨在改善抗原递送和T细胞激活.
与传统BCG相比,可能提高治疗疗效和降低毒性.

结论:

纳米BCG和基因工程BCG代表了膀癌免疫疗法的有前途的进展.
需要进一步的研究和开发来应对相关的挑战,并优化临床应用.
这些策略有可能使癌症治疗更有效,更安全.

关键词:

菌卡尔梅特 - 格林疫苗的疫苗膀癌是一种癌症.基因工程是一种基因工程.免疫治疗是一种免疫疗法.纳米载体纳米载体是什么

更多相关视频

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model

Published on: May 29, 2015

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...